Defibrillation testing at the time of implantable cardioverter defibrillator implantation: Results of the European Heart Rhythm Association survey

Europace

Volumn 13, Issue 4, 2011, Pages 581-582

  Morgan, John M ^a   Marinskis, Germanas ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Implantable cardioverter defibrillators; Safety; Testing

Indexed keywords

AMIODARONE;

ATTITUDE TO HEALTH; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; DEFIBRILLATOR; ELECTRODE; HEALTH SURVEY; HEART VENTRICLE FIBRILLATION; HUMAN; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT RESPONSE;

ATTITUDE OF HEALTH PERSONNEL; DEFIBRILLATORS, IMPLANTABLE; EUROPE; EVIDENCE-BASED MEDICINE; HEALTH SURVEYS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 79953790513     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur109     Document Type: Short Survey

References (4)

1. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm 2008;5:387-90.
2. Viskin S, Rosso R. The top 10 reasons to avoid defibrillation threshold testing during ICD implantation. Heart Rhythm 2008;5:391-3.
3. Brignole M, Raciti G, Bongiorni MG, De Martino G, Favale S, Gasparini M et al. Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide survey. Europace 2007;9:540-3. (Pubitemid 47249446)
4. Gold MR, Higgins S, Klein R, Gilliam FR, Kopelman H, Hessen S et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS). Circulation 2002;105:2043-8. (Pubitemid 34465266)